NATCO PHARMA LTD.
NSE : NATCOPHARMBSE : 524816ISIN
CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse
: Natco
BSE995.80-23.05 (-2.26 % )
PREV CLOSE (Rs.) 1018.85
OPEN PRICE (Rs.) 1017.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 56489
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE994.95 -21.1 (-2.08 % )
PREV CLOSE(Rs.) 1016.05
OPEN PRICE (Rs.) 1016.10
BID PRICE (QTY) 994.95 (20 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 487398
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 02-Feb-2024 | 14-Feb-2024 | Interim Dividend & Quarterly Results |
| 03-Nov-2023 | 14-Nov-2023 | Quarterly Results & Interim Dividend |
| 31-Jul-2023 | 09-Aug-2023 | Quarterly Results & Interim Dividend |
| 19-May-2023 | 29-May-2023 | Audited Results |
| 02-Mar-2023 | 08-Mar-2023 | Buy Back of Shares |
| 31-Jan-2023 | 09-Feb-2023 | Quarterly Results & Interim Dividend |
| 31-Oct-2022 | 10-Nov-2022 | Quarterly Results & Second Interim Dividend |
| 01-Aug-2022 | 09-Aug-2022 | Interim Dividend & Quarterly Results |
| 20-May-2022 | 30-May-2022 | Audited Results |
| 07-Feb-2022 | 14-Feb-2022 | Third Interim Dividend & Quarterly Results |
